PPARG and Alzheimer disease: Preclinical studies showed that immunomodulation by peroxisome proliferator-activated receptor (PPAR)-γ using the antidiabetic compound pioglitazone rescues neuronal spine density 4 and spatial learning performance 5 in mouse AD models.